RHYTHM Biosciences Ltd (RHY) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.037x

Based on the latest financial reports, RHYTHM Biosciences Ltd (RHY) has a cash flow conversion efficiency ratio of -1.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.22 Million ≈ $-1.57 Million USD) by net assets (AU$2.14 Million ≈ $1.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RHYTHM Biosciences Ltd balance sheet quality to measure how much of total assets are equity-financed.

RHYTHM Biosciences Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how RHYTHM Biosciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check RHYTHM Biosciences Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

RHYTHM Biosciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RHYTHM Biosciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mon Courtier Energie Groupe SA PA:ALMCE	0.068x
ZICOM Group Ltd AU:ZGL	0.499x
Rohas Tecnic Bhd KLSE:9741	-0.016x
Welsbach Technology Metals Acquisition Corp NASDAQ:WTMA	0.018x
Inception Growth Acquisition Ltd NASDAQ:IGTA	0.109x
Heavy Minerals Ltd AU:HVY	-0.149x
Schlatter Industries AG SW:STRN	-0.197x
Shreyans Industries Limited NSE:SHREYANIND	0.040x

Annual Cash Flow Conversion Efficiency for RHYTHM Biosciences Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of RHYTHM Biosciences Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of RHYTHM Biosciences Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$659.89K ≈ $466.92K	AU$-2.92 Million ≈ $-2.07 Million	-4.427x	+37.45%
2024-06-30	AU$867.17K ≈ $613.58K	AU$-6.14 Million ≈ $-4.34 Million	-7.077x	-497.55%
2023-06-30	AU$5.87 Million ≈ $4.16 Million	AU$-6.96 Million ≈ $-4.92 Million	-1.184x	-40.49%
2022-06-30	AU$7.37 Million ≈ $5.22 Million	AU$-6.21 Million ≈ $-4.40 Million	-0.843x	+73.37%
2021-06-30	AU$1.71 Million ≈ $1.21 Million	AU$-5.40 Million ≈ $-3.82 Million	-3.165x	-112.71%
2020-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-2.74 Million ≈ $-1.94 Million	-1.488x	-195.92%
2019-06-30	AU$5.85 Million ≈ $4.14 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.503x	-152.79%
2018-06-30	AU$8.30 Million ≈ $5.87 Million	AU$-1.65 Million ≈ $-1.17 Million	-0.199x	-2177166.56%
2017-06-30	AU$1.42 Million ≈ $1.01 Million	AU$-13.00 ≈ $-9.20	0.000x	--

About RHYTHM Biosciences Ltd

AU:RHY Australia Diagnostics & Research

Market Cap

$21.35 Million

AU$30.17 Million AUD

Market Cap Rank

#24882 Global

#1034 in Australia

Share Price

AU$0.09

Change (1 day)

+6.98%

52-Week Range

AU$0.08 - AU$0.26

All Time High

AU$2.00